REUBEN SELTZER Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for REUBEN SELTZER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of REUBEN SELTZER. REUBEN SELTZER is Director in HI TECH PHARMACAL CO INC ($HITK) and Vice Chairman, Business Dev't in HI TECH PHARMACAL CO INC ($HITK) and Vice Chairman-Business Dev't in HI TECH PHARMACAL CO INC ($HITK).
Latest Insider Trading Transactions of REUBEN SELTZER
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 10 2013 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Vice Chairman, Busi ... | Option Exercise | M | 10.93 | 11,250 | 122,963 | 0 | |
Oct 10 2013 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Vice Chairman, Busi ... | Sell | S | 43.13 | 11,250 | 485,213 | 521,510 | 532.8 K to 521.5 K (-2.11 %) |
Oct 10 2013 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Vice Chairman, Busi ... | Buy | M | 10.93 | 11,250 | 122,963 | 532,760 | 521.5 K to 532.8 K (+2.16 %) |
Oct 04 2013 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Vice Chairman, Busi ... | Option Exercise | M | 13.50 | 11,250 | 151,875 | 0 | |
Oct 04 2013 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Vice Chairman, Busi ... | Sell | S | 43.13 | 11,250 | 485,213 | 521,510 | 532.8 K to 521.5 K (-2.11 %) |
Oct 04 2013 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Vice Chairman, Busi ... | Buy | M | 13.50 | 11,250 | 151,875 | 532,760 | 521.5 K to 532.8 K (+2.16 %) |
Nov 09 2012 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Vice Chairman-Busin ... | Option Exercise | A | 31.93 | 50,000 | 1,596,500 | 50,000 | |
Oct 18 2012 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Vice Chairman, Busi ... | Sell | S | 32.56 | 6,800 | 221,408 | 521,160 | 528 K to 521.2 K (-1.29 %) |
Oct 18 2012 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Vice Chairman, Busi ... | Sell | S | 33.47 | 3,200 | 107,104 | 527,690 | 530.9 K to 527.7 K (-0.60 %) |
Oct 15 2012 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Vice Chairman, Busi ... | Option Exercise | M | 8.31 | 11,250 | 93,488 | 0 | |
Oct 15 2012 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Vice Chairman, Busi ... | Sell | S | 33.01 | 11,250 | 371,363 | 531,160 | 542.4 K to 531.2 K (-2.07 %) |
Oct 15 2012 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Vice Chairman, Busi ... | Buy | M | 8.31 | 11,250 | 93,488 | 542,410 | 531.2 K to 542.4 K (+2.12 %) |
Oct 15 2012 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Vice Chairman, Busi ... | Sell | S | 34.01 | 707 | 24,045 | 531,160 | 531.9 K to 531.2 K (-0.13 %) |
Oct 15 2012 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Vice Chairman, Busi ... | Sell | S | 33.18 | 9,293 | 308,342 | 531,867 | 541.2 K to 531.9 K (-1.72 %) |
Jul 17 2012 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Vice Chairman-Busin ... | Option Exercise | A | 32.59 | 50,000 | 1,629,500 | 50,000 | |
Jul 17 2012 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Vice Chairman-Busin ... | Gift | G | 0.00 | 700 | 0 | 541,160 | 541.9 K to 541.2 K (-0.13 %) |
Nov 14 2011 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Option Exercise | M | 3.84 | 56,250 | 216,000 | 0 | |
Nov 14 2011 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Option Exercise | M | 4.29 | 11,250 | 48,263 | 0 | |
Nov 14 2011 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Buy | M | 3.84 | 56,250 | 216,000 | 541,535 | 485.3 K to 541.5 K (+11.59 %) |
Nov 14 2011 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Buy | M | 4.29 | 11,250 | 48,263 | 485,285 | 474 K to 485.3 K (+2.37 %) |
Nov 15 2010 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Vice Chairman-Busin ... | Option Exercise | A | 22.25 | 95,000 | 2,113,750 | 95,000 | |
Apr 15 2010 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 24.25 | 20,000 | 485,000 | 473,535 | 493.5 K to 473.5 K (-4.05 %) |
Jan 19 2010 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Option Exercise | M | 1.78 | 26,250 | 46,725 | 0 | |
Jan 19 2010 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 25.70 | 26,250 | 674,625 | 493,535 | 519.8 K to 493.5 K (-5.05 %) |
Jan 19 2010 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Buy | M | 1.78 | 26,250 | 46,725 | 519,785 | 493.5 K to 519.8 K (+5.32 %) |
Nov 16 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Option Exercise | A | 19.59 | 25,000 | 489,750 | 25,000 | |
Oct 16 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Option Exercise | M | 1.78 | 30,000 | 53,400 | 26,250 | |
Oct 16 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 25.00 | 5,916 | 147,900 | 299,303 | 305.2 K to 299.3 K (-1.94 %) |
Oct 16 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 24.91 | 30,000 | 747,300 | 493,535 | 523.5 K to 493.5 K (-5.73 %) |
Oct 16 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Buy | M | 1.78 | 30,000 | 53,400 | 523,535 | 493.5 K to 523.5 K (+6.08 %) |
Oct 01 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 21.57 | 16,556 | 357,113 | 305,119 | 321.7 K to 305.1 K (-5.15 %) |
Oct 01 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 22.90 | 6,845 | 156,751 | 493,535 | 500.4 K to 493.5 K (-1.37 %) |
Oct 01 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 21.40 | 12,000 | 256,800 | 500,380 | 512.4 K to 500.4 K (-2.34 %) |
Sep 16 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 21.04 | 27,000 | 568,080 | 321,675 | 348.7 K to 321.7 K (-7.74 %) |
Sep 16 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 21.00 | 20,000 | 420,000 | 512,380 | 532.4 K to 512.4 K (-3.76 %) |
Sep 16 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 21.00 | 25,000 | 525,000 | 532,380 | 557.4 K to 532.4 K (-4.49 %) |
Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Option Exercise | M | 2.00 | 6,750 | 13,500 | 0 | |
Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | M | 12.77 | 6,750 | 86,198 | 557,380 | 564.1 K to 557.4 K (-1.20 %) |
Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Buy | M | 2.00 | 6,750 | 13,500 | 564,130 | 557.4 K to 564.1 K (+1.21 %) |
Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 12.75 | 51,239 | 653,297 | 557,380 | 608.6 K to 557.4 K (-8.42 %) |
Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 12.76 | 1,110 | 14,164 | 608,619 | 609.7 K to 608.6 K (-0.18 %) |
Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 12.77 | 5,000 | 63,850 | 609,729 | 614.7 K to 609.7 K (-0.81 %) |
Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 12.80 | 2,224 | 28,467 | 614,729 | 617 K to 614.7 K (-0.36 %) |
Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 12.81 | 400 | 5,124 | 616,953 | 617.4 K to 617 K (-0.06 %) |
Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 12.82 | 1,200 | 15,384 | 617,353 | 618.6 K to 617.4 K (-0.19 %) |
Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 12.83 | 800 | 10,264 | 618,553 | 619.4 K to 618.6 K (-0.13 %) |
Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 12.84 | 250 | 3,210 | 619,353 | 619.6 K to 619.4 K (-0.04 %) |
Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 12.85 | 500 | 6,425 | 619,603 | 620.1 K to 619.6 K (-0.08 %) |
Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 12.91 | 600 | 7,746 | 620,103 | 620.7 K to 620.1 K (-0.10 %) |
Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 12.96 | 2,452 | 31,778 | 620,703 | 623.2 K to 620.7 K (-0.39 %) |
Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 12.97 | 600 | 7,782 | 623,155 | 623.8 K to 623.2 K (-0.10 %) |
Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 13.00 | 2,200 | 28,600 | 623,755 | 626 K to 623.8 K (-0.35 %) |
Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 13.01 | 600 | 7,806 | 625,955 | 626.6 K to 626 K (-0.10 %) |
Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 13.02 | 300 | 3,906 | 626,555 | 626.9 K to 626.6 K (-0.05 %) |
Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 13.03 | 1,400 | 18,242 | 626,855 | 628.3 K to 626.9 K (-0.22 %) |
Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 13.05 | 200 | 2,610 | 628,255 | 628.5 K to 628.3 K (-0.03 %) |
Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 13.06 | 500 | 6,530 | 628,455 | 629 K to 628.5 K (-0.08 %) |
Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 13.07 | 840 | 10,979 | 628,955 | 629.8 K to 629 K (-0.13 %) |
Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 13.08 | 500 | 6,540 | 629,795 | 630.3 K to 629.8 K (-0.08 %) |
Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 13.10 | 100 | 1,310 | 630,295 | 630.4 K to 630.3 K (-0.02 %) |
Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 13.15 | 710 | 9,337 | 630,395 | 631.1 K to 630.4 K (-0.11 %) |
Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 13.18 | 100 | 1,318 | 631,105 | 631.2 K to 631.1 K (-0.02 %) |
Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 13.19 | 275 | 3,627 | 631,205 | 631.5 K to 631.2 K (-0.04 %) |
Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 13.20 | 500 | 6,600 | 631,480 | 632 K to 631.5 K (-0.08 %) |
Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 13.21 | 100 | 1,321 | 631,980 | 632.1 K to 632 K (-0.02 %) |
Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 13.22 | 300 | 3,966 | 632,080 | 632.4 K to 632.1 K (-0.05 %) |
Mar 27 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Option Exercise | M | 1.64 | 56,250 | 92,250 | 0 | |
Mar 27 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Buy | M | 1.64 | 56,250 | 92,250 | 629,890 | 573.6 K to 629.9 K (+9.81 %) |
Nov 17 2008 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Option Exercise | A | 5.83 | 25,000 | 145,750 | 25,000 | |
Sep 16 2008 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Option Exercise | A | 9.70 | 25,000 | 242,500 | 25,000 | |
Jul 21 2008 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Option Exercise | M | 1.89 | 6,750 | 12,758 | 0 | |
Jul 21 2008 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | M | 10.69 | 12 | 128 | 573,640 | 573.7 K to 573.6 K (0.00 %) |
Jul 21 2008 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | M | 10.68 | 12 | 128 | 573,652 | 573.7 K to 573.7 K (0.00 %) |
Jul 21 2008 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | M | 10.65 | 339 | 3,610 | 573,664 | 574 K to 573.7 K (-0.06 %) |
Jul 21 2008 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | M | 10.64 | 200 | 2,128 | 574,003 | 574.2 K to 574 K (-0.03 %) |
Jul 21 2008 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | M | 10.58 | 100 | 1,058 | 574,203 | 574.3 K to 574.2 K (-0.02 %) |
Jul 21 2008 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | M | 10.53 | 127 | 1,337 | 574,303 | 574.4 K to 574.3 K (-0.02 %) |
Jul 21 2008 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | M | 10.52 | 600 | 6,312 | 574,430 | 575 K to 574.4 K (-0.10 %) |
Jul 21 2008 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | M | 10.51 | 100 | 1,051 | 575,030 | 575.1 K to 575 K (-0.02 %) |
Jul 21 2008 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | M | 10.50 | 5,260 | 55,230 | 575,130 | 580.4 K to 575.1 K (-0.91 %) |
Jul 21 2008 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Buy | M | 1.89 | 6,750 | 12,758 | 580,390 | 573.6 K to 580.4 K (+1.18 %) |
Jan 11 2008 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Option Exercise | M | 2.33 | 56,250 | 131,063 | 0 | |
Jan 11 2008 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Buy | M | 2.33 | 56,250 | 131,063 | 572,440 | 516.2 K to 572.4 K (+10.90 %) |
Nov 19 2007 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Option Exercise | A | 9.65 | 11,250 | 108,563 | 11,250 | |
Oct 16 2007 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Option Exercise | M | 2.39 | 6,750 | 16,133 | 0 | |
Oct 16 2007 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 11.25 | 5,450 | 61,313 | 516,190 | 521.6 K to 516.2 K (-1.04 %) |
Oct 16 2007 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 11.28 | 200 | 2,256 | 521,640 | 521.8 K to 521.6 K (-0.04 %) |
Oct 16 2007 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 11.29 | 200 | 2,258 | 521,840 | 522 K to 521.8 K (-0.04 %) |
Oct 16 2007 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 11.31 | 100 | 1,131 | 522,040 | 522.1 K to 522 K (-0.02 %) |
Oct 16 2007 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 11.33 | 200 | 2,266 | 522,140 | 522.3 K to 522.1 K (-0.04 %) |
Oct 16 2007 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 11.36 | 200 | 2,272 | 522,340 | 522.5 K to 522.3 K (-0.04 %) |
Oct 16 2007 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 11.39 | 400 | 4,556 | 522,540 | 522.9 K to 522.5 K (-0.08 %) |
Oct 16 2007 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Buy | M | 2.39 | 6,750 | 16,133 | 522,940 | 516.2 K to 522.9 K (+1.31 %) |
Nov 13 2006 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Option Exercise | A | 14.99 | 11,250 | 168,638 | 11,250 | |
Jan 17 2006 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Option Exercise | M | 1.78 | 22,500 | 40,050 | 33,750 | |
Jan 17 2006 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 28.80 | 22,500 | 648,000 | 513,373 | 535.9 K to 513.4 K (-4.20 %) |
Jan 17 2006 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Buy | M | 1.78 | 22,500 | 40,050 | 535,873 | 513.4 K to 535.9 K (+4.38 %) |
Jan 09 2006 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 44.13 | 4,000 | 176,520 | 210,760 | 214.8 K to 210.8 K (-1.86 %) |
Jan 09 2006 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 44.62 | 4,000 | 178,480 | 214,760 | 218.8 K to 214.8 K (-1.83 %) |
Jan 09 2006 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 44.69 | 4,000 | 178,760 | 218,760 | 222.8 K to 218.8 K (-1.80 %) |
Jan 09 2006 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 45.05 | 2,300 | 103,615 | 222,760 | 225.1 K to 222.8 K (-1.02 %) |
Jan 09 2006 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 44.84 | 1,700 | 76,228 | 225,060 | 226.8 K to 225.1 K (-0.75 %) |
Jan 09 2006 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 44.02 | 4,000 | 176,080 | 226,760 | 230.8 K to 226.8 K (-1.73 %) |
Jan 09 2006 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 46.67 | 5,000 | 233,350 | 342,249 | 347.2 K to 342.2 K (-1.44 %) |
Jan 09 2006 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 44.62 | 5,000 | 223,100 | 347,249 | 352.2 K to 347.2 K (-1.42 %) |
Jan 09 2006 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 44.84 | 10,000 | 448,400 | 352,249 | 362.2 K to 352.2 K (-2.76 %) |
Dec 22 2005 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 44.09 | 4,000 | 176,360 | 230,760 | 234.8 K to 230.8 K (-1.70 %) |
Dec 22 2005 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 44.04 | 4,000 | 176,160 | 234,760 | 238.8 K to 234.8 K (-1.68 %) |
Dec 22 2005 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 44.46 | 4,000 | 177,840 | 238,760 | 242.8 K to 238.8 K (-1.65 %) |
Dec 22 2005 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 44.03 | 4,000 | 176,120 | 242,760 | 246.8 K to 242.8 K (-1.62 %) |
Dec 22 2005 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 44.22 | 4,000 | 176,880 | 246,760 | 250.8 K to 246.8 K (-1.60 %) |
Dec 22 2005 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 44.02 | 12,141 | 534,447 | 362,249 | 374.4 K to 362.2 K (-3.24 %) |
Dec 22 2005 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 43.53 | 15,000 | 652,950 | 374,390 | 389.4 K to 374.4 K (-3.85 %) |
Dec 15 2005 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Option Exercise | A | 37.43 | 7,500 | 280,725 | 7,500 | |
Dec 15 2005 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Gift | G | 0.00 | 4,000 | 0 | 389,390 | 393.4 K to 389.4 K (-1.02 %) |
Sep 28 2005 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Option Exercise | M | 3.08 | 4,500 | 13,874 | 0 | |
Sep 28 2005 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 30.10 | 3,400 | 102,340 | 250,760 | 254.2 K to 250.8 K (-1.34 %) |
Sep 28 2005 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 30.17 | 700 | 21,119 | 254,160 | 254.9 K to 254.2 K (-0.27 %) |
Sep 28 2005 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 30.18 | 600 | 18,108 | 254,860 | 255.5 K to 254.9 K (-0.23 %) |
Sep 28 2005 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 30.19 | 400 | 12,076 | 255,460 | 255.9 K to 255.5 K (-0.16 %) |
Sep 28 2005 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 30.20 | 1,000 | 30,200 | 255,860 | 256.9 K to 255.9 K (-0.39 %) |
Sep 28 2005 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 30.21 | 2,665 | 80,510 | 256,860 | 259.5 K to 256.9 K (-1.03 %) |
Sep 28 2005 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 30.22 | 700 | 21,154 | 259,525 | 260.2 K to 259.5 K (-0.27 %) |
Sep 28 2005 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 30.23 | 500 | 15,115 | 260,225 | 260.7 K to 260.2 K (-0.19 %) |
Sep 28 2005 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 30.24 | 200 | 6,048 | 260,725 | 260.9 K to 260.7 K (-0.08 %) |
Sep 28 2005 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 30.00 | 8,116 | 243,480 | 260,925 | 269 K to 260.9 K (-3.02 %) |
Sep 28 2005 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 30.27 | 200 | 6,054 | 269,041 | 269.2 K to 269 K (-0.07 %) |
Sep 28 2005 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 30.11 | 3,019 | 90,902 | 269,241 | 272.3 K to 269.2 K (-1.11 %) |
Sep 28 2005 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 30.10 | 3,500 | 105,350 | 272,260 | 275.8 K to 272.3 K (-1.27 %) |
Sep 28 2005 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 29.50 | 7,000 | 206,500 | 393,390 | 400.4 K to 393.4 K (-1.75 %) |
Sep 28 2005 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 29.52 | 1,400 | 41,328 | 400,390 | 401.8 K to 400.4 K (-0.35 %) |
Sep 28 2005 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 29.55 | 200 | 5,910 | 401,790 | 402 K to 401.8 K (-0.05 %) |
Sep 28 2005 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 29.57 | 600 | 17,742 | 401,990 | 402.6 K to 402 K (-0.15 %) |
Sep 28 2005 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 29.58 | 300 | 8,874 | 402,590 | 402.9 K to 402.6 K (-0.07 %) |
Sep 28 2005 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 29.59 | 100 | 2,959 | 402,890 | 403 K to 402.9 K (-0.02 %) |
Sep 28 2005 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 29.60 | 1,700 | 50,320 | 402,990 | 404.7 K to 403 K (-0.42 %) |
Sep 28 2005 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 29.61 | 100 | 2,961 | 404,690 | 404.8 K to 404.7 K (-0.02 %) |
Sep 28 2005 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 29.62 | 400 | 11,848 | 404,790 | 405.2 K to 404.8 K (-0.10 %) |
Sep 28 2005 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 29.64 | 500 | 14,820 | 405,190 | 405.7 K to 405.2 K (-0.12 %) |
Sep 28 2005 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 29.65 | 100 | 2,965 | 405,690 | 405.8 K to 405.7 K (-0.02 %) |
Sep 28 2005 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 29.50 | 3,100 | 91,450 | 405,790 | 408.9 K to 405.8 K (-0.76 %) |
Sep 28 2005 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 29.51 | 600 | 17,706 | 408,890 | 409.5 K to 408.9 K (-0.15 %) |
Sep 28 2005 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 29.53 | 500 | 14,765 | 409,490 | 410 K to 409.5 K (-0.12 %) |
Sep 28 2005 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 29.56 | 800 | 23,648 | 409,990 | 410.8 K to 410 K (-0.19 %) |
Sep 28 2005 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 29.57 | 100 | 2,957 | 410,790 | 410.9 K to 410.8 K (-0.02 %) |
Sep 28 2005 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Buy | M | 3.08 | 4,500 | 13,874 | 410,890 | 406.4 K to 410.9 K (+1.11 %) |
Jul 19 2005 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Option Exercise | M | 5.08 | 4,500 | 22,874 | 0 | |
Jul 19 2005 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 28.02 | 400 | 11,208 | 406,390 | 406.8 K to 406.4 K (-0.10 %) |
Jul 19 2005 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 28.03 | 300 | 8,409 | 406,790 | 407.1 K to 406.8 K (-0.07 %) |
Jul 19 2005 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 28.04 | 400 | 11,216 | 407,090 | 407.5 K to 407.1 K (-0.10 %) |